A multi-center study on the early warning of home monitoring with smart wearable devices to improve adverse pregnancy outcomes in pregnant women with gestational hypertension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083911

Enrollment

Unknown

Registered

2024-05-07

Start date

2024-05-07

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational hypertension

Interventions

Study Group :Using remote monitoring equipment to monitor blood pressure (4 times a day, resting state measurement of blood pressure at 8:00, 12:00, 16:00, 22:00).

Control Group:The control group was managed according to the routine outpatient management of high-risk pregnant women.

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 2000 pregnant women with gestational hypertension or critical hypertension (systolic blood pressure at 135-139mmHg; diastolic blood pressure at 85-89mmHg), the inclusion criteria are: ? singleton pregnancy; ? age: 18-45 years old and pregnant women according to the age of the control group; ? pregnant women with complete clinical data; ? pregnant women and their family members informed and agreed to the study, and signed an informed consent

Exclusion criteria

Exclusion criteria: ? Combined serious mental disorder ? Speech communication disorder ? Inability to use the monitoring system normally

Design outcomes

Primary

Measure	Time frame
Blood pressure;blood oxygen;fetal heart rate;gestational outcomes;	—

Secondary

Measure	Time frame
gestational weeks;premature births;NICU admission number;	—

Countries

China

Contacts

Public ContactYinghao

Shanghai First Maternity & Infant Hospital

stephenying_2011@163.com+86 136 6190 2783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026